Page last updated: 2024-08-24

trovafloxacin and Cancer of Liver

trovafloxacin has been researched along with Cancer of Liver in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Abdull Razis, AF; Ibrahim, MD; Ioannides, C; Iori, R; Kntayya, SB; Mohd Ain, N	1

Other Studies

1 other study(ies) available for trovafloxacin and Cancer of Liver

Article	Year
Induction of Apoptosis and Cytotoxicity by Isothiocyanate Sulforaphene in Human Hepatocarcinoma HepG2 Cells. Nutrients, 2018, Jun-04, Volume: 10, Issue:6 Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Carcinoma, Hepatocellular; Caspases; Cell Cycle Checkpoints; Cell Proliferation; Cell Survival; Cisplatin; Dose-Response Relationship, Drug; Glucosinolates; Hep G2 Cells; HT29 Cells; Humans; Isothiocyanates; Liver Neoplasms; MCF-7 Cells; Sulfoxides; Time Factors	2018

Article

Year

Induction of Apoptosis and Cytotoxicity by Isothiocyanate Sulforaphene in Human Hepatocarcinoma HepG2 Cells.

Nutrients, 2018, Jun-04, Volume: 10, Issue:6

Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Carcinoma, Hepatocellular; Caspases; Cell Cycle Checkpoints; Cell Proliferation; Cell Survival; Cisplatin; Dose-Response Relationship, Drug; Glucosinolates; Hep G2 Cells; HT29 Cells; Humans; Isothiocyanates; Liver Neoplasms; MCF-7 Cells; Sulfoxides; Time Factors

2018